Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

HealthCor Catalio Acquisition (HCAQ) Competitors

HCAQ vs. CHEK, GEHC, PHG, HOLX, BFLY, NNOX, AVTX, NSPR, VERU, and OCX

Should you be buying HealthCor Catalio Acquisition stock or one of its competitors? The main competitors of HealthCor Catalio Acquisition include Check-Cap (CHEK), GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Hologic (HOLX), Butterfly Network (BFLY), Nano-X Imaging (NNOX), Avalo Therapeutics (AVTX), InspireMD (NSPR), Veru (VERU), and OncoCyte (OCX).

HealthCor Catalio Acquisition vs.

HealthCor Catalio Acquisition (NASDAQ:HCAQ) and Check-Cap (NASDAQ:CHEK) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HealthCor Catalio AcquisitionN/AN/AN/AN/AN/A
Check-CapN/AN/A-$17.57M-$3.00-0.26

Company Net Margins Return on Equity Return on Assets
HealthCor Catalio AcquisitionN/A N/A N/A
Check-Cap N/A N/A N/A

84.2% of HealthCor Catalio Acquisition shares are owned by institutional investors. Comparatively, 1.1% of Check-Cap shares are owned by institutional investors. 0.5% of Check-Cap shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Check-Cap received 370 more outperform votes than HealthCor Catalio Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
HealthCor Catalio AcquisitionN/AN/A
Check-CapOutperform Votes
370
61.67%
Underperform Votes
230
38.33%

In the previous week, Check-Cap had 3 more articles in the media than HealthCor Catalio Acquisition. MarketBeat recorded 3 mentions for Check-Cap and 0 mentions for HealthCor Catalio Acquisition. Check-Cap's average media sentiment score of 0.93 beat HealthCor Catalio Acquisition's score of 0.00 indicating that Check-Cap is being referred to more favorably in the news media.

Company Overall Sentiment
HealthCor Catalio Acquisition Neutral
Check-Cap Positive

Summary

Check-Cap beats HealthCor Catalio Acquisition on 4 of the 5 factors compared between the two stocks.

Remove Ads
Get HealthCor Catalio Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCAQ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HCAQ vs. The Competition

MetricHealthCor Catalio AcquisitionX IndustryMedical SectorNASDAQ Exchange
Market Cap$19.09M$13.01B$5.64B$8.08B
Dividend YieldN/A1.74%4.89%4.04%
P/E RatioN/A19.3123.7319.00
Price / SalesN/A8.85381.75120.61
Price / CashN/A11.9038.0534.64
Price / BookN/A2.276.904.26
Net IncomeN/A$344.53M$3.18B$247.00M

HealthCor Catalio Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HCAQ
HealthCor Catalio Acquisition
N/A$0.90
+1.8%
N/A-26.7%$19.09MN/A0.002Gap Up
High Trading Volume
CHEK
Check-Cap
0.4809 of 5 stars
$0.77
-4.0%
N/A-61.0%$4.51MN/A-0.2680Analyst Forecast
Short Interest ↑
Gap Down
GEHC
GE HealthCare Technologies
3.329 of 5 stars
$85.36
-1.4%
$97.67
+14.4%
-8.0%$39.03B$19.67B19.7150,000Analyst Upgrade
Positive News
PHG
Koninklijke Philips
2.6464 of 5 stars
$26.75
-3.0%
N/A+25.0%$25.14B$18.02B-31.8478,200Short Interest ↑
HOLX
Hologic
4.8986 of 5 stars
$65.62
+1.7%
$84.62
+28.9%
-18.0%$14.72B$4.04B20.707,063Short Interest ↓
BFLY
Butterfly Network
2.0626 of 5 stars
$2.54
-11.1%
$3.00
+18.3%
+129.3%$692.33M$82.06M-5.51460Gap Down
NNOX
Nano-X Imaging
2.0692 of 5 stars
$5.43
-10.1%
$17.50
+222.3%
-42.0%$313.74M$10.68M-6.39190Gap Down
AVTX
Avalo Therapeutics
3.3256 of 5 stars
$7.19
-7.3%
$35.33
+391.4%
+42.4%$74.73M$820,000.000.0040Short Interest ↑
Positive News
NSPR
InspireMD
2.0428 of 5 stars
$2.82
-0.7%
$4.75
+68.4%
+9.2%$73.56M$6.82M-3.7650Analyst Forecast
News Coverage
Gap Up
VERU
Veru
2.9056 of 5 stars
$0.50
-2.6%
$4.00
+700.0%
-25.0%$73.19M$16.89M-1.92230Positive News
Gap Down
OCX
OncoCyte
2.3512 of 5 stars
$4.17
+6.9%
$4.42
+5.9%
+38.6%$72.78M$709,000.000.00120High Trading Volume
Remove Ads

Related Companies and Tools


This page (NASDAQ:HCAQ) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners